PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) Blues
Nick Beije, Wassim Abida, Emmanuel S. Antonarakis, Elena Castro, Ronald de Wit, Karim Fizazi, Silke Gillessen, Maha Hussain, Joaquı́n Mateo, Michael J. Morris, David Olmos, Oliver Sartor, Adam Sharp, Christopher J. Sweeney, Johann S. de Bono
Topics & Concepts
MedicineBluesProstate cancerAndrogen receptorDNA repairPoly ADP ribose polymeraseOncologyInternal medicineCancerBioinformaticsDNAGeneticsBiologyArtArt historyPolymerasePARP inhibition in cancer therapyProstate Cancer Treatment and ResearchIntegrated Circuits and Semiconductor Failure Analysis